Good day, ladies and gentlemen, and welcome to Kopin's Q3 2022 Earnings Call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Richard Sneider. Please go ahead. Thank you, operator. Welcome, everyone, and thank you for joining us this morning. John will begin today's call with a brief discussion of his new role with Kopin, and then he'll introduce Michael Murray, our new CEO, who will discuss his strategy for Kopin and our progress in the Q3. I'll review the Q3 of 2022 results at a high level, and after concluding remarks from Michael, we'll be happy to take your questions. I would like to remind everyone that during today's call taking place on Tuesday, November 1st, 2022, we will be making forward-looking stagtements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on the company's current expectations, projections, beliefs, and estimates and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those forward-looking statements. Potential risks include, but not limited to, demand for our products, operating results of our subsidiaries, market conditions, and other factors discussed in our most recent annual report on Form 10-K and other documents filed with the Securities and Exchange Commission. The company undertakes no obligation to update the forward-looking statements made during today's call. With that, I'll turn the call over to John. Good morning, and thank you all for joining us to discuss our Q3 Fiscal 2022 Operating Results. I'm calling in from Asia as I'm meeting with our OLED partners. Hopefully, this call is clear to you. I'm delighted to and excited to introduce Michael Murray as Kopin's new CEO. I believe Michael has the experience to successfully lead Kopin to its next stage of growth. I will remain chairman of Kopin and will work closely with Michael on this important transition while I continue to focus on the strategy and scientific matters, especially related to AR and VR. I will now turn the call over to Michael. Thanks, John. Good morning, everyone. I also hope you can hear me clearly as I'm calling in from Europe, where I'm meeting with current and potential customers as well as some partners. First, I'd like to take a moment to thank John, the Kopin board, and the talented and hardworking folks of Kopin for their warm welcome to the company. John has led our company through many business cycles and growth over the past 35+ years, and we're fortunate to have him remain as chairman of the board and a critical visionary thought leader and partner in our technical strategy as I lead the company into the next stage of growth. I decided to join Kopin due to the company's unique culture of innovation, technical curiosity, and a rich blend of consumer, industrial, and military opportunities, which closely aligns with my background and interests. I also believe that I bring a more systematic approach to business development, product commercialization, and program management, while still facilitating the culture of technical curiosity and freedom of experimentation, which is core to the Kopin culture. With that said, we'll turn to the Q3 results. We had a good quarter. The total revenue is up 23% over the Q3 of last year, our third consecutive quarter of sequential growth. Top line was driven by 50% year-over-year growth in product revenue. Interestingly, our Defense and Consumer revenues were very strong in Q3 of 2022, with 115% and 76% year-over-year growth, respectively. The growth in these segments was partially offset, however, by a 37% year-over-year decline in our Industrial revenues. Now, while the supply chain issues appear to be lessening, we continue to experience challenges, one of which resulted, unfortunately, in a warranty issue within the quarter, which we have since addressed, and we are hopeful that the $1 million charge will be the last related to this specific situation. Currently, the supply chain cadence appears to be improving, though we do continue to experience intermittent challenges from time to time. Importantly, we are on track for growth in the second half of the year to exceed the first half as promised, and as a result, the fifth consecutive year Kopin will achieve year-over-year growth. I think this is a good segue to discuss our outlook. Beginning in Q4 and throughout 2023, my focus will be driving on yield improvements and achieving on-time in-full deliveries while identifying opportunities to reduce costs. We expect these steps to result in improved margins and cash flow. I also see significant revenue opportunities in 2023. As an example, our AR and VR market is an exciting market in which Kopin is well-positioned for growth. We are working hard to develop and further develop the technology required to mature this market. For example, we are the world's largest provider of this technology, and the world's largest customers demand displays with higher brightness at lower power and thinner sizes. Again, as a reminder, Kopin is the world leader in supplying this technology. Other emerging markets for AR and VR, such as healthcare, are still nascent. However, we do see adoption rates increasing in these markets, which will also drive higher growth in 2023. Lastly, our Military and Defense business has significant order cover heading into 2023. Furthermore, on recent customer visits, I clearly saw and heard how much they value Kopin's vast display capabilities, our SWaP-C value, and the unique ability to offer complex integrated optical display assemblies. The growing global concerns surrounding the war in Ukraine have generated further opportunities for Kopin to expand our customer base and support our current customers with new international variants of our products. Specifically, the recently announced $3 million initial production award is a great example of this. We see this order and in similar potential deals like this as exciting new opportunities to expand our Defense business. My trip to Europe this week directly supports that global Defense business and opportunity level. Before I turn the call over to Rich, however, to review our Q3 financials in more detail, I did want to make one comment on our financial position. The $900,000 raised from the ATM this past quarter was related to the sale announced actually in Q2 before I joined Kopin, which was completed in Q3. I'm confident that we have the financial resources to fund our growth through consistent and continuous improvement in our operations, improve programmatic management and contracting strategies. These things will help us drive increased profits to the bottom line. Rich, over to you. Thank you, Michael. Turning to our financial results. Product revenues for the Q3 ended September 24th, 2022 were $9.9 million, compared with $6.6 million for the Q3 ended September 25th, 2021. A 50% increase year-over-year. The increase in Product revenues were driven by a 115% increase in Defense revenues and a 76% increase in Consumer revenues. These were partially offset by a 37% decline in Industrial revenues. Funded Research and Development revenues were $3.4 million for the Q3 of 2022, compared with $4.1 million for the Q3 of 2021, an 18% decline. The decline in funded Research Development programs is due to transitioning programs into production and billings from subcontractors. Total revenues from Q3 2022 were $13.4 million versus $10.9 million for the prior year, an overall 23% increase year-over-year. Cost of goods sold for the Q3 of 2022 was $8 million or 81% of product revenues, compared with $5.1 million or 78% for the Q3 of last year. The increase in cost of product revenues as a percent of net product revenues for the three months ended September 25th, 2022, as compared to the prior year, was primarily due to a $1 million warranty charge, partially related to the quality issues from a vendor that Michael discussed. R&D expenses in the Q3 of 2022 were $3.4 million, compared with $3.8 million for the Q3 of 2021. The decrease in 2022 Q3 R&D expense as compared to the prior year was equally split between internal R&D and customer-funded R&D activities. SG&A expenses were $4.3 million in the Q3 of 2022, compared to $4 million in the Q3 of 2021. SG&A increases for the three months ended September 24th, 2022, as compared to the three months ended September 25th, 2021, were primarily due to an increase in compensation and professional fees, which were partially offset by lower stock-based compensation. Other income and expense was an expense of approximately $2.1 million for the Q3 of 2022, compared with an expense of $51,000 for the Q3 of 2021. In the Q3 of 2022, we recorded a $2 million non-cash impairment charge related to an investment in Asia. During the three months ended September 24th, 2022, we recorded $112,000 of foreign currency losses as compared to $29,000 of foreign currency losses for the three months ended September 25th, 2021. Turning to the bottom line, the net loss attributed to Kopin for the Q3 was approximately $4.5 million or $0.05 per share, compared with $2.1 million or $0.02 per share for the Q3 of 2021. Net cash used in operating activities for the nine months ended September 24th, 2022, was approximately $15.6 million. Kopin's cash and marketable securities were approximately $15 million as of September 24th, as compared to $29 million at December 25th, 2021. We have no long-term debt. Q3 amounts for depreciation and stock compensation expense are attached in the table to the Q3 2022 press release. The amounts discussed above are based on current estimates, and listeners should review our Form 10-K for the Q3 of 2022 for any possible changes and, of course, additional disclosures. With that, I'll turn the call back over to Michael for closing remarks, and then we'll take your questions. Thanks very much, Rich. Ultimately, this quarter was a reflection of Kopin's resilience, hard work, and dedication to manage through global supply chain issues, the remnants, hopefully, of COVID, and deliver a solid result. We remain cautiously optimistic that we've identified and have mitigation plans for our supply chain challenges, and we expect to have a good Q4. Now, as we look forward, we are excited for the future and focused on pursuing an ambitious strategic growth plan while not losing sight of the current macro uncertainties. We remain optimistic and ever focused on the vision that has guided us from the beginning, to be a company where imagination and experimentation seeds innovation and invention, and that invention ignites innovation. This innovation is why customers have partnered with us for the past 35 years, and it's core of all the things that we do and achieve. Our goal now is to pair this innovation with a renewed focus of operational excellence, which will benefit our customers, our partners, employees, and our shareholders. From me to you and all of Kopin, thank you very much for your interest in Kopin, and we'll now be happy to answer any questions that you may have. Operator. Thank you. Ladies and gentlemen, if you'd like to ask a question, please signal by pressing star one on your telephone keypad. If you're using a speakerphone, please make sure your mute function is turned off to allow your signal to reach our equipment. Again, please press star one to ask a question. We'll pause for just a moment to allow everyone an opportunity to signal for questions. We'll take our first question from Glenn Mattson with Ladenburg. Please go ahead. Yeah. Hi. Thanks for taking the question. Michael, first one for you. You know, interested, given your background and history and everything. You talked a little bit about, you know, commercializing some of the great innovation that exists inside of Kopin. Can you just balance, like, how you intend to do that kind of thing in light of, you know, especially like in spaces like consumer, where maybe like the AR/VR market is, you know, maybe still emerging or nascent, as you mentioned, you know, some color on that'd be great. Sure. Glenn, was it? I think I got that right. Yep. Yep. Yeah, great question. So I think there's multiple strategies at play, Glenn. When you think about consumer and volume and display markets, Dr. Fan's been working very hard in China on that strategy with partnerships and exciting opportunities that we have there. When we look at Industrial and Enterprise technologies, that's more of a licensing model that we already have in place and really taking latent IP and IP that we can take to the market and monetizing it, and we'll do more of that in the future, because it's a great model for us and very profitable. Then when we think about defense business, I think there's opportunities there to use more of our technologies in the Defense market. One of the things that I've learned and will bring to Kopin is how to move up the value stack line. What I mean by that is our customers want us to provide them more capability. Defense companies these days don't want to necessarily do everything internally, and our biggest customers want us to do more. That, I think, is the way I would answer the question is for our Military business, which is our Defense business that pays the bills, you know, we're going to do more for our customers and monetize more of their system, move up the value stream and stack with them because they want us to, and we'll monetize that with us. On the Industrial front, we'll continue to do our IP licensing and expand the Palmmount business. Dr. Fan’s working on more of the strategy around how to move forward with higher volume OLED business with our partners, customers, and strategies in China. Those are the three aspects of our strategy that we’re moving forward with and we’ll refine more in the next month or two as we have our strategic plan updates. Great. Thanks for that color. The next one, I don't know if it's better for you, Mike, or for Rich, but you know, just can you give us a sense of on the Defense side, you know, some new programs have kind of emerged more recently. What stage you are in terms of low rate initial production versus full scale? On some of the existing ones that have been around for a while, can you give a sense of like the runway as we start to kind of think about a little more about 2023 and the outlook as we push out a little bit? [crosstalk]Go ahead, Richard. Go ahead, Mike. No, go ahead, Mike. No, I was just gonna answer with, I think folks are familiar with the FWS-I program. I think that's still got a lot of legs to it. We're in production with that and will be for quite some time, I believe. There are other offshoot programs with that that I don't have permission to state yet, but they're more on the International side of things. That's just coming into LRIP now or low rate initial productions. We have three or four other defense programs that are just hitting early stage productions that we're excited about. When you think about next year for us, we have a good blend of existing order book. To answer the question more succinctly, we have a great order book cover for next year for our Defense business, which is, you know, up, what was it, 115%, roughly speaking. We have that rolling into next year, and we also have some new programs with tier one customers that are just coming online. It's an exciting place to be. Rich, do you wanna add any color to that? No, I think that's exactly what I was gonna say. We have a very solid base and, you know, as we've talked about, you know, with the Common Helmet program for helicopter pilots, the International markets, a number of the other programs that have gone into low rate, we have excellent growth potentials on top of those. Great. That's. I'll jump back in the queue. Thanks, guys. As a reminder, star one for questions or comments, please. Star one. We'll take our next question from Kevin Dede with H.C. Wainwright. Please go ahead. Good morning, Mike, Rich, John. Thanks for dialing in from so far away. Mike, first, just welcome to the new role. It's great to hear from you, and apologies for not having been able to touch base earlier. I'm curious, though. You mentioned a systematic approach, and I'm wondering if you could characterize that for us. What, you know, what did you see when you walked in the door and started working on things, peeling the onion back? What do you think can change? How detailed will your oversight be on that type of thing, on those types of things? Then more specifically, what do you think you can do to improve yields as you've spoken to? Sure. Great question, Kevin. One of the things that I've learned in my career is that process does not stifle innovation if done properly. Innovation can exist and flourish through process and what have you. I think one of the things from a systematic approach is putting in an approach for innovation that still allows for free thinking, free form experimentation, and then monetizing that free form experimentation into innovation. That's the process. Keeping the great things about Kopin, which is the MIT type of culture of innovation, while making it monetizable and profitable, that's the systematic approach that I'm going to bring. I learned that at Analog Devices, a very innovative company, still full of great ideas and wonderful engineering capabilities, but they're able to monetize it very, very well. That's the type of systematic approach that I'm speaking of. Furthermore, we're embarking upon a revisit of our strategic plan this month, as well as a more robust budgeting process, which, you know, I think is important for the company. From there, we're going to look at the programmatic capabilities of the company in terms of running programs and making sure that we're delivering on time in full to our customer base. That's how I look at more of a systematic approach. While we put that in place, we don't wanna hinder any of our innovation or invention along the way. That's how I would answer that question, Kevin. Did I answer it fully for you? Yes. That helps. That helps a lot. Maybe you could get a little more granular as you discuss where you see yields and how you'll work- All right. -to improve those. Indeed. From a yield perspective, we have a lot of processes in the company that I think are good. We'll put in place more of an agile methodology when it comes to our programmatic reviews, as well as more statistical analysis or SPC thought processes around our manufacturing. That's already underway. That was already involved and in process within Kopin previously. However, the way that I look at statistical analysis of yields is a little bit different, and we'll look at it at a more broken down level so that we know if we're going wrong earlier in the process versus at the end of the process. It's more of a statistical approach, Kevin. Okay. You seem to be more comfortable about supply chain issues. Can you offer a little more insight on, I mean, given the short tenure, where your comfort is coming from? Sure. Mainly I understand the FPGA market very well. I think you'll find other companies such as Kopin are struggling with FPGA deliveries. I can mention five off the top of my head. They are getting better because of their supply chain is getting better, and that we've had direct relationships and conversations with the specific FPGA supplier that we work with. They're getting better clarity, therefore, we're getting better clarity and better confidence. That seems to be across the board. In fact, I was listening to Intel and their earnings call, and it seems like they're getting a hold of their supply chain. It's a ripple effect, Kevin. You know, we're at the end of that, but of that supply chain, I mean, I think we're just getting better clarity and better confidence that our suppliers are getting their supply chain corrected. Okay. I mean, everyone's spoken to the improvement in consumer, right? Well, actually more than doubled, I think, in business from the June quarter. I'm curious about what you see driving that and how consistent that sales level might be, albeit minor compared to the Defense business. It's still a nice little pop and potentially indicative. Indeed. Kevin, it's exactly right. It's off a smaller base, but having said that, it's about the funnel, and we're filling the funnel with new opportunities with Tier 1 customers, and they're starting to mature, as time goes on here. Because the market's maturing, and I think we're well-positioned for growth in it. The way I view the consumer business is that's the pop, that's the sizzle, right? We're positioned well. We have a strong portfolio of products. Dr. Fan's working on some really interesting things with our Chinese partners, that I think is gonna help fuel that growth. I think about the overall business. You know, as consumer grows, we're gonna have this wonderful base business that's profitable and will move along at a decent compound annual growth rate while, you know, the consumer business will ebb and flow as they do. But I do believe our consumer business will grow next year based on some of the LRIP that we've got there with some key customers. You're starting to hear some of the announcements that are coming out recently of Kopin being involved with Pancake Optics and some AR/VR headsets. Yeah, I think you're gonna hear more of those in the future. To that end, I highly recommend we'll be at CES this year, Kevin. Hopefully, you're able to come visit us, and you'll see some more of our new products in that suite. We're hopeful to have a great CES this year. I appreciate the invitation. I usually try to make it. It's always a big show for John. It's definitely being considered. Thanks very much. Last question for me, if I may, Mike. We talked about a, I think it was, $2 million. I can't get a P&L. It showed $2 million write off, and you spoke to $1 million. Can we just have a little more detail on that? It kind of went by a little too quick for me. Apologies for, you know, the burden of maybe not a complete deck that you're talking to here. Rich, do you wanna take that one? I'm sorry, Kevin. I got distracted by someone walking in my office. They didn't realize I'm on the call. Could you repeat the question? Yeah, sure. I was just wondering about the write down, Rich. I've- Sure. It showed as two, I think, on the P&L, and Michael mentioned one. I was just looking for a little more color on that. It seems that- Yeah. -you folks are confident that might be the end of it. Well, as you know, we have a number of investments, equity investments. In this particular case, we have a significant investment in a company located in Asia. Their business has been significantly affected by COVID. Every quarter we go through and do an impairment review on our investments. Based upon the current situation in Asia related to COVID and this customer, we did evaluation and determined it was impaired, and we took it. We did not fully write the investment off. We just wrote it down to what our analysis says it's worth. It's all part of the fair value accounting that the financial statements are based on. There's a lot of assumptions in there about future growth rates and so on and so forth, as promulgated by the accounting literature. It's a non-cash charge. You know, it's something we're required to do every quarter. It's directly related to the impacts of COVID in the countries that they operate in. Okay. Okay. The other $1 million was- Thank you very much, gentlemen. -the warranty issue. Thank you very much. Thanks, Kevin. Ladies and gentlemen, this concludes today's Q&A session and concludes today's conference. We appreciate your participation. You may now disconnect.